Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
VOCABRIA (CABOTEGRAVIR SODIUM) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
VOCABRIA
NDA
Get alerts
CABOTEGRAVIR SODIUM | N212887 | VIIV HEALTHCARE CO
1 strength
2 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
2 unique patents, 1 exclusivity by expiration date
Expired (1)
Active (1)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
Today
8410103
Feb. 4, 2031
10927129
Apr. 28, 2026
NCE
Jan. 21, 2026
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 30MG BASE
RLD
2 patents
1 exclusivity
▴
TABLET;ORAL | Approved: Jan 21, 2021
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8410103
Feb 4, 2031
—
Yes
Yes
U-3348
TREATMENT OF HIV-1 INFECTION IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 35 KG
—
10927129
Apr 28, 2026
—
Yes
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Jan 21, 2026
Expired